双特异性抗体在B细胞淋巴瘤:机制,有效性,毒性和管理
Ádám Jóna1,2, Dávid Tóthfalusi1,2, Árpád Illés1,2
1Department of Hematology, Faculty of Medicine, University of Debrecen, Member of ERN-EuroBloodNet (European Reference Network on Rare Haematological Diseases), H-4032 Debrecen, Hungary.
Medicina (Kaunas, Lithuania)
|February 27, 2026
概括
双特异性抗体 (BsAbs) 通过将T细胞与恶性B细胞联系起来,为B细胞淋巴瘤提供了一种新的治疗方法. 虽然有效,但管理诸如细胞因子释放综合征和感染之类的毒性对患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 双特异性抗体 (BsAbs) 是复发性/耐药性B细胞淋巴瘤的一个重大进展.
- 有限的传统治疗选择需要新的治疗策略.
研究的目的:
- 审查用于B细胞淋巴瘤治疗的CD20 × CD3双特异性抗体 (BsAbs).
- 详细介绍它们的机制,有效性和相关毒性的管理.
主要方法:
- 关于CD20 × CD3 BsAbs的文献综述 (莫苏涅图祖马布,epcoritamab,odronextamab,glofitamab). 这种药物可以用于治疗疾病.
- 分析它们的作用机制,临床疗效和安全性.
- 检查与免疫相关的毒性和感染风险.
主要成果:
- BsAbs在扩散大B细胞淋巴瘤和卵泡淋巴瘤中表现出显著的疗效,反应率高.
- 已被批准用于各种B细胞淋巴瘤,它们将恶性B细胞和T细胞连接起来以进行向溶解.
- 主要的毒性包括细胞因子释放综合征和免疫效应细胞相关的神经毒性综合征.
结论:
- BsAbs为B细胞淋巴瘤提供了一种"现成"的治疗选择.
- 对与免疫相关的毒性和感染进行全面的管理至关重要.
- 平衡有效性与毒性管理对于最佳的患者结果至关重要.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
B Cell Activation and Differentiation
17.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.4K
Special Features of Adaptive Immunity
3.7K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.7K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K


